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conjugated with tamoxifen and its anticancer potential against human breast cancer 
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ABSTRACT 
In this experiment, we aimed to fabricate SWCNT conjugated with tamoxifen and evaluated             
its anticancer potential against human breast cancer cells (MCF-7). The results showed that             
SWCNT was synthetized successfully using chemical vapor deposition (CVD) method. The           
results of Raman spectroscopy, SEM, and TEM analyses confirmed the synthesis of highly             
pure SWCNT. The functionalization of SWCNT was performed by oxidizing of SWCNT,            
attachment of polyethylene glycol (PEG) to oxidized SWCNT, and attachment of azelaic acid             
to the polyethylene glycol group. As a result, the SWCNT with free functional carboxylic              
acid and hydroxyl groups (SWCNT-PEG) was developed. The SWCNT-PEG was then           
conjugated with tamoxifen (SWCNT-PEG-TAM). The FT-IR together with NMR results          
confirmed the conjugation of tamoxifen to functionalized SWCNT (SWCNT-PEG-TAM).         
The cytotoxic concentrations (CC50) of SWCNT-PEG, tamoxifen, and SWCNT-PEG-TAM         
were >100, , and μg/ml, respectively. Linking tamoxifen to functionalized SWCNT enhanced            
the cytotoxic action of tamoxifen against breast cancer cells up to 2.3 times. The results of the                 
morphological examination and caspase-3 activity confirmed the higher cytotoxic action of           
SWCNT-PEG-TAM as compared to free tamoxifen. The results obtained in this study            
indicated that this delivery system enhanced the therapeutic effects and anticancer potential            
of tamoxifen against human breast cancer cells. 
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